Production (Stage)
Kiora Pharmaceuticals, Inc.
KPRX
$3.08
-$0.01-0.32%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 24.11M | 26.79M | 29.04M | 27.82M | 31.28M |
| Total Receivables | 2.06M | 871.40K | 2.15M | 3.67M | 2.00M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 213.00K | 2.04M | 175.80K | 195.80K | 182.30K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 728.60K | -- | 294.60K | 143.80K | 24.40K |
| Total Current Assets | 27.11M | 29.71M | 31.65M | 31.83M | 33.48M |
|
|
|||||
| Total Current Assets | 27.11M | 29.71M | 31.65M | 31.83M | 33.48M |
| Net Property, Plant & Equipment | 157.10K | 62.40K | 135.20K | 145.80K | 107.20K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 6.69M | 0.00 | 6.69M | 8.80M | 8.81M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 68.40K | 6.72M | 34.40K | 36.30K | 43.50K |
| Total Assets | 34.02M | 36.48M | 38.51M | 40.81M | 42.44M |
|
|
|||||
| Total Accounts Payable | 942.50K | 415.60K | 660.40K | 268.60K | 323.10K |
| Total Accrued Expenses | 1.07M | 2.26M | 1.56M | 1.25M | 1.22M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 71.60K | 23.40K | 33.40K | 42.10K | 47.90K |
| Total Finance Division Other Current Liabilities | 3.20M | 3.31M | 1.27M | 100.00K | -- |
| Total Other Current Liabilities | 3.20M | 3.31M | 1.27M | 100.00K | -- |
| Total Current Liabilities | 5.27M | 6.01M | 3.53M | 1.66M | 1.59M |
|
|
|||||
| Total Current Liabilities | 5.27M | 6.01M | 3.53M | 1.66M | 1.59M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 87.50K | 33.80K | 39.20K | 40.20K | 46.40K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 4.96M | 4.68M | 4.91M | 6.02M | 5.90M |
| Total Liabilities | 10.32M | 10.72M | 8.48M | 7.71M | 7.54M |
|
|
|||||
| Common Stock & APIC | 169.57M | 169.42M | 169.26M | 169.09M | 168.69M |
| Retained Earnings | -145.58M | -143.38M | -139.16M | -135.75M | -133.52M |
| Treasury Stock & Other | -297.20K | -282.20K | -75.20K | -245.70K | -264.40K |
| Total Common Equity | 23.70M | 25.76M | 30.03M | 33.10M | 34.90M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
|
|
|||||
| Total Common Equity | 23.70M | 25.76M | 30.03M | 33.10M | 34.90M |
| Total Preferred Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 23.70M | 25.76M | 30.03M | 33.10M | 34.90M |
|
|
|||||